Director Nagelberg buys 150 shares of HKHC at $33.96; cluster pattern with 3 other insiders in 14 days.
Director Allison Nagelberg purchased 150 shares at $33.96 on 2026-03-20, increasing her holdings by 60.0% from 250 to 400 shares. This purchase occurs as part of a broader cluster pattern, with 3 other insiders also buying within the past 14 days, which may signal coordinated confidence in the stock's value at current levels. Her prior two open-market purchases at HKHC both showed positive 90-day returns (+0.0% and +55.0%), establishing a pattern of well-timed accumulation at this ticker. The stock currently trades at $34.19, up 18.9% over 30 days and 44.1% over 90 days—well above the levels Nagelberg accumulated at ($33.96), though still -27.3% from the 52-week high of $47.00. Against the company's strong recent fundamentals (revenue growth of +27.4% year-over-year, net income of $7,235,000.00), the elevated P/E of 79.51 and recent momentum warrant assessment of whether insiders are positioned ahead of or late into a valuation reset.
Director Allison Nagelberg buys 50 HKHC shares at $38.99; cluster pattern with 4 other insiders buying within 14 days
Director Nagelberg purchased 50 shares at $38.99 on 2024-11-14, increasing holdings by 25.0% to 250 shares total. The transaction occurs within a cluster buy pattern involving 4 other insiders in the same 14-day window, suggesting coordinated accumulation. However, the company's fundamentals raise significant concerns: net income stands at $-38.2M against revenue of $15.4M, annual revenue has declined 79.5%, and the stock trades at a P/E of 50.00 despite losses. Nagelberg's prior open-market buy at this ticker on 2024-09-05 returned -9.7% over 30 days, providing limited evidence of accurate timing on this position.
Director Nagelberg buys 200 HKHC shares at $25.48; 3 other insiders bought within 14 days amid -79.5% annual revenue decline.
Director Allison Nagelberg purchased 200 shares at $25.48 on 2024-09-05, just two trading days after HKHC's IPO. The transaction coincides with a multi-insider buying cluster: 3 other insiders acquired shares within the past 14 days. This concurrent insider accumulation during a recent listing could indicate internal confidence, though context is critical. The company's fundamentals present significant headwinds: annual revenue contracted 79.5% (from prior year), the latest quarter showed negative net income of $-450,000.00 against revenue of $718,000.00, and the P/E ratio of 824.67 reflects a non-normalized earnings profile. The cluster buy pattern alongside a newly public company and stressed financials warrants investor attention to whether insiders are supporting the IPO valuation or responding to material undisclosed information.
